Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients receiving care at accredited cancer hospitals in Pennsylvania

Lindsay Sabik, Ph.D., associate professor and vice chair for research in the Department of Health Policy and Management at the University of Pittsburgh School of Public Health and member of the Biobehavioral Cancer Control Program at UPMC Hillman Cancer Center. Image courtesy of Lindsay Sabik


May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients receiving care at accredited cancer hospitals in Pennsylvania, according to a study published in Health Services Research by University of Pittsburgh researchers.

“There’s evidence that when people get treatment for cancer at accredited facilities specializing in cancer care, they tend to have better outcomes,” said senior author Lindsay Sabik, Ph.D., associate professor and vice chair for research in the Department of Health Policy and Management at the Pitt School of Public Health and member of the Biobehavioral Cancer Control Program at UPMC Hillman Cancer Center. “Our findings suggest that ACA insurance expansions make a difference for increasing access to care at these centers.”

Before the ACA, about one in five Americans aged 26 to 64 lacked health insurance, according to Sabik. The legislation was passed in 2010 to help address this gap, but it wasn’t until 2014 that its various provisions — including expansion of Medicaid eligibility to anyone with an income up to 138% of the federal poverty level, the establishment of a health insurance marketplace and ensuring health insurance policies had minimum essential coverage — were all in effect.

And although the Medicaid expansion was initially written as a national policy, the U.S. Supreme Court later ruled that states could choose whether to expand their Medicaid programs. To date, 40 states, including Pennsylvania, have adopted the Medicaid expansion and 10 have not.

To investigate whether the ACA affected patient access to accredited cancer hospitals — which include National Cancer Institute-designated Comprehensive Cancer Centers (NCI-CCCs) and those with American College of Surgeons Commission on Cancer (CoC) accreditation — in Pennsylvania, Sabik and her team compared pre- and post-ACA time periods of 2010-2013 and 2014-2019.

They used the Pennsylvania Cancer Registry to identify patients aged 26 to 64 who received surgery as part of their initial treatment for lung, prostate or colorectal cancer. 

Because the registry does not include individual patients’ incomes or insurance eligibility, the researchers used statewide data to identify patients who lived in areas with high rates of uninsurance in the pre-ACA period, reasoning that these people would be more likely to receive insurance benefits through the ACA.

By comparing the percentage of these high baseline uninsured patients who received treatment at accredited hospitals to patients in areas with low uninsurance rates, the researchers tried to account for other factors beyond the ACA that may drive where patients receive care.

There was an increase of 6.2 percentage points in patients from high baseline uninsurance areas receiving care at NCI-CCCs after the ACA.

Just three hospitals in Pennsylvania, including UPMC Hillman Cancer Center, are NCI-CCCs, while 56 centers — including the three with NCI designation — have CoC accreditation.

Analyzing patients who received care at CoC-accredited hospitals, the researchers found that there was an increase of 3.9 percentage points after the ACA, but it was not statistically significant.

“Although the ACA is over 10 years old, our findings are relevant because there are continued policy debates about further expanding Medicaid and Medicare and, on the flip side, some policymakers want to roll back elements of the legislation,” said Sabik. “For states that have not yet expanded Medicaid, our study suggests that this is important for improving access to high quality cancer care.”

Other authors on the study were Youngmin Kwon, Ph.D., Coleman Drake, Ph.D., Jonathan Yabes, Ph.D., Manisha Bhattacharya, M.D., M.B.A., Zhaojun Sun, Ph.D., and Bruce L. Jacobs, M.D., M.P.H., all of Pitt, and Cathy J. Bradley, Ph.D., of the University of Colorado and the Colorado School of Public Health.

This research was supported by the Agency for Healthcare Research and Quality (R01HS027396).

For more information: https://www.pitt.edu/


Related Content

News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | Artificial Intelligence

June 11, 2024 — A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and ...

Time June 11, 2024
arrow
News | FDA

June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a ...

Time June 10, 2024
arrow
News | Breast Imaging

June 7, 2024 — Scholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization ...

Time June 07, 2024
arrow
News | Radiopharmaceuticals and Tracers

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
arrow
News | Information Technology

June 4, 2024 — International medical imaging IT and cybersecurity company Sectra has launched a new diagnostic IT module ...

Time June 04, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

As we flip the page to a new month on our calendars, here is a look at the Top 10 pieces of content viewers were reading ...

Time June 04, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Lung Imaging

May 31, 2024 — To further the fight against global lung cancer, Qure.ai, a leader in healthcare artificial intelligence ...

Time May 31, 2024
arrow
Subscribe Now